Security Trust Center
Alamar Biosciences delivers automated, high-throughput solutions for ultra-sensitive protein analysis. Our NULISA™ Chemistry enhances sensitivity and dynamic range while reducing background noise, supporting both qPCR and NGS. The NULISAseq Inflammation Panel—covering 200+ immune and inflammatory markers—runs on the fully automated ARGO™ System, requiring less than 30 minutes of hands-on time.
Our commitment to data privacy and security is foundational to our operations. This Trust Center offers detailed information about our security practices and serves as a gateway for requesting access to our security and compliance documentation.
Gates Foundation
Genentech
Stanford University
Sanofi
Banner Health
Biognosys
AbbVie Inc.
Michaeljfox.Org
SciLifeLab
Alzheimer's Drug Discovery Foundation
University of British Columbia
DZNE
Subprocessors
Subprocessors
SOC 2 Type 2 - Clean Opinion
SOC 2 Type 2 Report Now Available
June 3, 2026
We are pleased to announce that Alamar Biosciences has successfully completed our SOC 2 Type 2 examination, conducted by A-LIGN. The audit covers the period October 15, 2025 through January 31, 2026 and addresses the Trust Services Criteria for the Security category.
The examination resulted in an unqualified (clean) opinion, confirming that our controls were suitably designed and operated effectively throughout the audit period to meet our service commitments and system requirements.
What This Means for You
A SOC 2 Type 2 report provides independent, third-party assurance that Alamar Biosciences' security controls are not only in place, but have been tested and validated over time. This is a higher standard than a SOC 2 Type 1 report, which evaluates design only. Our Type 2 report gives customers, partners, and stakeholders greater confidence in how we safeguard the data and systems entrusted to us.
Continued Investment in Security
Completion of this audit reflects our ongoing commitment to maintaining a rigorous security program. Since the close of the audit period, we have continued to strengthen our security posture, including the completion of an identity and access management migration to Microsoft Entra ID, the deployment of endpoint privilege management controls across all managed endpoints, and active infrastructure improvements underway.
A SOC 2 bridge letter is also available in this Trust Center, covering the period from February 1, 2026 through the date of issuance and confirming the continued operation of our controls beyond the audit period.
How to Request the Report
The full SOC 2 Type 2 report is available to customers, partners, and prospective business partners under NDA. To request access, please submit a request directly through this Trust Center.
Security Trust Center Launch
We are excited to announce the launch of our Security Trust Center, a centralized hub for sharing information about our security, compliance, and privacy practices.
The Trust Center provides customers, partners, and stakeholders with greater transparency into how we safeguard data and uphold the highest standards of security.
What You’ll Find in the Trust Center
- Compliance and Certifications – Details on our SOC 2 Type 1 certification and our progress toward SOC 2 Type 2, expected by Q2 next year.
- Security Practices – Information on network security, access control, encryption, and monitoring.
- Policies and Governance – Acceptable use, incident response, data protection, and more.
- Continuous Monitoring – Updates on our 24/7 SOC operations and real-time threat detection.
Why It Matters
Our mission is to build trust through transparency. By making our security documentation and controls accessible, we help customers make informed decisions and demonstrate our commitment to protecting sensitive information.